← Back to reading roomBrand-name research

Ozempic in an online offer: familiarity is not a full assessment

Recognising a brand does not establish the prescription, indication or commercial arrangement.

Find out what is actually being offered

An image of a familiar brand can identify a topic without promising that the service will prescribe or supply it to you. Ask what part of the process the advertisement describes: an assessment, a possible prescription or a specific product offer. Those descriptions create different expectations.

Let the clinician explain the intended indication

A brand’s public visibility does not answer why it is being discussed in an individual consultation. Ask the clinician to explain the proposed use and the product information relevant to that decision. Do not use a generic weight-management article as a substitute for the actual prescribing conversation.

Trace the cost beyond the brand recognition

Clarify whether a quote concerns the clinical service, medication or both. If insurance is involved, confirm the details for the particular proposal rather than relying on a broad statement that coverage may be available. Familiarity with a name should not hide uncertainty about what the payment includes.

About the information in this guide

Educational context draws on public FDA and NIDDK materials. Provider descriptions are not independent audits or patient testing. See our editorial approach for the scope and limitations of our coverage.

Next: the provider checklist →